Tagraxofusp

1 Drug classified under this active ingredient

CD123-directed cytotoxin. Tagraxofusp 1.15 mg/vial.
CD123-directed cytotoxin tagraxofusp
 VIAL: conc. for sol. for infus. 1X  1 mg/ml
Admin. at 12 mcg/kg IV over 15 min. 1/d on days 1 to 5 of a 21-d
cycle. Dosing period may be extend. for dose delays up to day 10 of the cycle. Cont. until dis. progress. or unaccept. tox.
Tmt. of blastic plasmacytoid dendritic cell neoplasm
(BPDCN) in adults
C/I:Hypersens.